NasdaqCM - Delayed Quote USD

Akso Health Group (AHG)

1.5700
-0.0300
(-1.87%)
At close: May 16 at 4:00:00 PM EDT
Loading Chart for AHG
  • Previous Close 1.6000
  • Open 1.5200
  • Bid --
  • Ask --
  • Day's Range 1.5001 - 1.6500
  • 52 Week Range 0.6210 - 2.3530
  • Volume 15,423
  • Avg. Volume 32,669
  • Market Cap (intraday) 621.973M
  • Beta (5Y Monthly) -0.21
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0800
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Aug 1, 2018
  • 1y Target Est --

Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscope. In addition, it is involved in the provision of health treatment services. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.

www.ahgtop.com

9

Full Time Employees

March 31

Fiscal Year Ends

Recent News: AHG

View More

Performance Overview: AHG

Trailing total returns as of 5/17/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

AHG
6.08%
MSCI WORLD (^990100-USD-STRD)
4.19%

1-Year Return

AHG
144.93%
MSCI WORLD (^990100-USD-STRD)
11.25%

3-Year Return

AHG
70.65%
MSCI WORLD (^990100-USD-STRD)
40.65%

5-Year Return

AHG
56.22%
MSCI WORLD (^990100-USD-STRD)
0.00%

Compare To: AHG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AHG

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    626.15M

  • Enterprise Value

    539.53M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    28.27

  • Price/Book (mrq)

    3.12

  • Enterprise Value/Revenue

    63.81

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -77.92%

  • Return on Assets (ttm)

    -3.73%

  • Return on Equity (ttm)

    -6.41%

  • Revenue (ttm)

    8.45M

  • Net Income Avi to Common (ttm)

    -6.58M

  • Diluted EPS (ttm)

    -0.0800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    91.37M

  • Total Debt/Equity (mrq)

    2.37%

  • Levered Free Cash Flow (ttm)

    403.14k

Research Analysis: AHG

View More

Company Insights: AHG

Research Reports: AHG

View More

People Also Watch